A multicentre, open-label, Phase I study investigating the safety, tolerability, and efficacy of 177Lu-SSO110 with 68Ga-SSO120 companion imaging in participants with extensive stage small cell lung cancer (ES-SCLC) who are on maintenance treatment with immune checkpoint inhibition (The LuSato1 Study)

  • Arulananda, Surein (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 94123
NMA SSA Reference Number: SSA/94123/MonH-2023-375356(v1)
Monash Health Local Reference: RES-23-0000-066A
StatusActive
Effective start/end date22/08/23 → 21/08/28